LMO2 and acute lymphoblastic leukemia: ChIP-seq studies using human ETP-ALL explants identified several binding sites for LMO2 within the regulatory regions of the FLT3 locus associated with open chromatin that is normally closed in DN3 thymocytes (Fig. 5B).